Grimm Lars J, Enslow Michael, Ghate Sujata V
Duke University Medical Center, Department of Radiology, Durham, NC.
J Breast Imaging. 2019 Mar 13;1(1):37-42. doi: 10.1093/jbi/wby014.
The purpose of this study was to determine the malignancy rate of solitary MRI masses with benign BI-RADS descriptors.
A retrospective review was conducted of all breast MRI reports that described a mass with a final BI-RADS assessment of 3, 4, or 5, from February 1, 2005, through February 28, 2014 (n = 1510). Studies were excluded if the mass was not solitary, did not meet formal criteria for a mass, or had classically suspicious BI-RADS features (e.g., washout kinetics, and spiculated margin). The masses were reviewed by 2 fellowship-trained breast radiologists who reported consensus BI-RADS mass margin, shape, internal-enhancement, and kinetics descriptors. The T2 signal was reported as hyperintense if equal to or greater than the signal intensity of the axillary lymph nodes. Pathology results or 2 years of imaging follow-up were recorded. Comparisons were made between mass descriptors and clinical outcomes.
There were 127 women with 127 masses available for analysis. There were 76 (60%) masses that underwent biopsy for an overall malignancy rate of 4% (5/127): 2 ductal carcinoma in situ (DCIS) and 3 invasive ductal carcinoma. The malignancy rate was 2% (1/59) for T2 hyperintense solitary masses. The malignancy rate was greater than 2% for all of the following BI-RADS descriptors: oval (3%, 3/88), round (5%, 2/39), circumscribed (4%, 5/127), homogeneous (4%, 3/74), and dark internal septations (4%, 2/44).
T2 hyperintense solitary masses without associated suspicious features have a low malignancy rate, and they could be considered for a BI-RADS 3 final assessment.
本研究旨在确定具有良性BI-RADS描述符的孤立性MRI乳腺肿块的恶性率。
对2005年2月1日至2014年2月28日期间所有最终BI-RADS评估为3、4或5级的乳腺MRI报告进行回顾性分析(n = 1510)。若肿块不是孤立性的、不符合肿块的正式标准或具有典型可疑的BI-RADS特征(如廓清动力学和毛刺状边缘),则排除该研究。由2名接受过乳腺放射学 fellowship培训的放射科医生对肿块进行评估,他们报告一致的BI-RADS肿块边缘、形状、内部强化和动力学描述符。如果T2信号强度等于或大于腋窝淋巴结的信号强度,则报告为高信号。记录病理结果或2年的影像随访情况。对肿块描述符与临床结果进行比较。
127名女性的127个肿块可供分析。76个(60%)肿块接受了活检,总体恶性率为4%(5/127):2例导管原位癌(DCIS)和3例浸润性导管癌。T2高信号孤立性肿块的恶性率为2%(1/59)。以下所有BI-RADS描述符的恶性率均大于2%:椭圆形(3%,3/88)、圆形(5%,2/39)、边界清晰(4%,5/127)、均匀(4%,3/74)和内部有暗分隔(4%,2/44)。
无相关可疑特征的T2高信号孤立性肿块恶性率较低,可考虑最终评估为BI-RADS 3级。